Advertisement

Topics

Aimmune's peanut allergy therapy closes in on approval with promising Phase 3 data http://bit.ly/2URxTUW  #PeanutAllergy @aimmune #pharmapic.twitter.com/BDaNu2EuWf

06:46 EDT 26 Mar 2019 | Pharmafile

Aimmune's peanut allergy therapy closes in on approval with promising Phase 3 data http://bit.ly/2URxTUW 

Original Article: Aimmune's peanut allergy therapy closes in on approval with promising Phase 3 data http://bit.ly/2URxTUW  #PeanutAllergy @aimmune #pharmapic.twitter.com/BDaNu2EuWf

NEXT ARTICLE

More From BioPortfolio on "Aimmune's peanut allergy therapy closes in on approval with promising Phase 3 data http://bit.ly/2URxTUW  #PeanutAllergy @aimmune #pharmapic.twitter.com/BDaNu2EuWf"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...